These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29876775)

  • 21. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
    Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z
    BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
    McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
    Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnic background has minimal impact on the etiology of nephrolithiasis.
    Maloney ME; Springhart WP; Ekeruo WO; Young MD; Enemchukwu CU; Preminger GM
    J Urol; 2005 Jun; 173(6):2001-4. PubMed ID: 15879804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of being overweight on urinary metabolic risk factors for kidney stone formation.
    Shavit L; Ferraro PM; Johri N; Robertson W; Walsh SB; Moochhala S; Unwin R
    Nephrol Dial Transplant; 2015 Apr; 30(4):607-13. PubMed ID: 25362001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Feb; 183(2):576-9. PubMed ID: 20018328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism.
    Osther PJ; Bollerslev J; Hansen AB; Engel K; Kildeberg P
    Urol Res; 1993 May; 21(3):169-73. PubMed ID: 8342250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients Attending Shared Medical Appointments for Metabolic Stone Prevention Have Decreased Stone Risk Factors.
    Jhagroo RA; Nakada SY; Penniston KL
    J Endourol; 2016 Nov; 30(11):1262-1268. PubMed ID: 27673722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of restrictive bariatric surgery on urinary stone risk factors.
    Semins MJ; Asplin JR; Steele K; Assimos DG; Lingeman JE; Donahue S; Magnuson T; Schweitzer M; Matlaga BR
    Urology; 2010 Oct; 76(4):826-9. PubMed ID: 20381135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty-four-hour urine constituents in stone formers: a study from the northeast part of Peninsular Malaysia.
    Hussein NS; Sadiq SM; Kamaliah MD; Norakmal AW; Gohar MN
    Saudi J Kidney Dis Transpl; 2013 May; 24(3):630-7. PubMed ID: 23640651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.